Detalles de la búsqueda
1.
Advancing therapeutic complement inhibition in hematologic diseases: PNH and beyond.
Blood
; 139(25): 3571-3582, 2022 06 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34482398
2.
Low-dose non-steroidal anti-inflammatory drugs: a promising approach for the treatment of symptomatic bone marrow failure in Ghosal hematodiaphyseal dysplasia.
Haematologica
; 2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38497148
3.
Current use of androgens in bone marrow failure disorders: a report from the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation.
Haematologica
; 109(3): 765-776, 2024 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37199126
4.
Predictors for improvement in patient-reported outcomes: post hoc analysis of a phase 3 randomized, open-label study of eculizumab and ravulizumab in complement inhibitor-naive patients with paroxysmal nocturnal hemoglobinuria.
Ann Hematol
; 103(1): 5-15, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37804344
5.
Peripheral blood stem cell versus bone marrow graft for patients ≥60 years undergoing reduced intensity conditioning haploidentical transplantation for acute myeloid leukemia in complete remission: An analysis of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Am J Hematol
; 99(7): 1250-1256, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38778766
6.
HLA-haploidentical stem cell transplantation in children with inherited bone marrow failure syndromes: A retrospective analysis on behalf of EBMT severe aplastic Anemia and pediatric diseases working parties.
Am J Hematol
; 99(6): 1066-1076, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38497679
7.
Efficacy, Safety and Quality of Life of Pegcetacoplan in Japanese Patients With Paroxysmal Nocturnal Hemoglobinuria Treated Within the Phase 3 PEGASUS Trial.
Acta Haematol
; 2024 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38615657
8.
Allogeneic transplantation in acute myelogenous leukemia: a comprehensive single institution's experience.
Haematologica
; 108(9): 2369-2379, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36951151
9.
Graft-versus-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMT.
Haematologica
; 108(9): 2305-2315, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36951165
10.
Concomitant Immunosuppressive Therapy and Eculizumab Use in Patients with Paroxysmal Nocturnal Hemoglobinuria: An International PNH Registry Analysis.
Acta Haematol
; 146(1): 1-13, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36108594
11.
Should Transplantation Still Be Considered for Ph1-Negative Myeloproliferative Neoplasms in Transformation?
Biol Blood Marrow Transplant
; 26(6): 1160-1170, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32119970
12.
Azithromycin Use and Increased Cancer Risk among Patients with Bronchiolitis Obliterans after Hematopoietic Cell Transplantation.
Biol Blood Marrow Transplant
; 26(2): 392-400, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31682980
13.
Long-term outcome of a randomized controlled study in patients with newly diagnosed severe aplastic anemia treated with antithymocyte globulin and cyclosporine, with or without granulocyte colony-stimulating factor: a Severe Aplastic Anemia Working Party Trial from the European Group of Blood and Marrow Transplantation.
Haematologica
; 105(5): 1223-1231, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31582549
14.
Long-term event-free survival, chimerism and fertility outcomes in 234 patients with sickle-cell anemia younger than 30 years after myeloablative conditioning and matched-sibling transplantation in France.
Haematologica
; 105(1): 91-101, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31097628
15.
Sequential allogeneic hematopoietic stem cell transplantation for active refractory/relapsed myeloid malignancies: results of a reduced-intensity conditioning preceded by clofarabine and cytosine arabinoside, a retrospective study on behalf of the SFGM-TC.
Ann Hematol
; 99(8): 1855-1862, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32564196
16.
Epstein-Barr Virus-Associated Post-Transplantation Lymphoproliferative Disease in Patients Who Received Anti-CD20 after Hematopoietic Stem Cell Transplantation.
Biol Blood Marrow Transplant
; 25(12): 2490-2500, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31421238
17.
SARS-CoV-2 vaccination in 361 non-transplanted patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria.
Haematologica
; 109(1): 283-286, 2024 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37584297
18.
Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference Center for Aplastic Anemia.
Haematologica
; 104(2): 256-262, 2019 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30262561
19.
BAM conditioning before autologous transplantation for lymphoma: a study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
Ann Hematol
; 98(8): 1973-1980, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31111177
20.
Use of eltrombopag in aplastic anemia in Europe.
Ann Hematol
; 98(6): 1341-1350, 2019 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-30915499